Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Dynavax Stock Is Rising Today

TheMotleyFool

0 0

Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 3.6% as of 11:38 a.m. EDT on Thursday after having gained as much as 6.9% earlier in the session. The stock's rise came following the company's announcement that it has signed a deal with Bavarian Nordic to market and distribute its hepatitis B vaccine Heplisav B in Germany.

Dynavax received market authorization for Heplisav B from the European Commission in February. However, that regulatory win was only the first step for the company in commercializing its hepatitis B vaccine throughout the European Union.

Image source: Getty Images.

Source Fool.com

Like: 0

DVAX

Share